Institut de Chimie & Biologie des Membranes & des Nano-objets • Bordeaux

LIA France-Japan GEM Réseau RMN Aquitain Master AC2QMAPS IPEP master UREKA UMT FOLIES INDIA
Offres d'Emploi Plateau Technique Conseil d'Unité Animation Scientifique WEB Editorial Committee Hygiène & Sécurité Communication Administration Directoire Scientifique Direction
Sophie Zinn-Justin, 14 April 2017, 11 am, IECB Christina Sizun, 18 May 2017, 4 pm, ENSCBP Cécile Feuillie, 16 February 2017, 4 PM, ENSCBP Félix M. Goñi, 8 december 2016, 4 pm, ENSCBP Félix M. Goñi, 17 november 2016, 4 pm, ENSCBP Carl Creutz, 20 october 2016, 4 pm, ENSCBP Diego Romero, 30 september 2016, 11 am, IECB A. Ciaccafava, 8 september 2016, 14h, ENSCBP A. Ramamoorthy, 16 June 2016, 16h, ENSCBP Alexandre de Brevern, 2 june 2016, ENSCBP Isabelle Landrieu, 26 May, 16h, ENSCBP Frances Sepavoric, 12 May, 16h, ENSCBP Thomas Pradeu, 7 April 2016, 9h, ENSCBP Françoise Argoul, 3 march 2016, 16h, ENSCBP Corinne Loutelier-Bourhis, 16/12/2015, 16h Aristotelis XENAKIS, 3 december 2015, 16h Fabian Kiessling, 26 november 2015, 11h Michaël Molinari, 20 november 2015, 11h Dipankar Das Sarma, 28 October 2015, 14h. Olivier Donard, 22 october 2015, 16h, ENSCBP E. Morvan & A.Grelard, 17/12/2015, 16h, ENSCBP Christophe Cullin, 10 september 2015, 14 h Brigitte Lindet, 18 June 2015, 16h, ENSCBP(B) Marion Decossas, 4 June 2015, 16h, ENSCBP(B) Pascale Schellenberger, 21 Mai 2015, 16h F. Leal-Calderon, 7 May 2015, 16h, ENSCBP(B) Ibrahim Abdulhalim, 9 April 2015, 14h, ENSCBP Manon Carré, 26 March 2015, 14h, ENSCBP(B) C. Bure & JM Schmitter, 19 March 2015, 16h T. Ogata & H. Ihara, 17 March 2015, 11h, IECB Banafshe Larijani, 12 March 2015, 16h, ENSCBP
Événements Nouveau
Partenariat Congés Formation Admin CBMN Conseil Institut/Scientifique
Affiliations Les sites CBMN
LIA France-Japan GEM Réseau RMN Aquitain Master AC2QMAPS IPEP master UREKA UMT FOLIES INDIA
Offres d'Emploi Plateau Technique Conseil d'Unité Animation Scientifique WEB Editorial Committee Hygiène & Sécurité Communication Administration Directoire Scientifique Direction
Chimie Biophysique Chimie Biomimétique et Thérapeuti... Biologie et Biotechnologie Administration
Sophie Zinn-Justin, 14 April 2017, ... Christina Sizun, 18 May 2017, 4 pm,... Cécile Feuillie, 16 February 2017,... Félix M. Goñi, 8 december 2016, 4... Félix M. Goñi, 17 november 2016, ... Carl Creutz, 20 october 2016, 4 pm,... Diego Romero, 30 september 2016, 11... A. Ciaccafava, 8 september 2016, 14... A. Ramamoorthy, 16 June 2016, 16h,... Alexandre de Brevern, 2 june 2016, ... Isabelle Landrieu, 26 May, 16h, ENS... Frances Sepavoric, 12 May, 16h, ENS... Thomas Pradeu, 7 April 2016, 9h, EN... Françoise Argoul, 3 march 2016, 1... Corinne Loutelier-Bourhis, 16/12/20... Aristotelis XENAKIS, 3 december 201... Fabian Kiessling, 26 november 2015,... Michaël Molinari, 20 november 2015... Dipankar Das Sarma, 28 October 2015... Olivier Donard, 22 october 2015, 16... E. Morvan & A.Grelard, 17/12/2015, ... Christophe Cullin, 10 september 201... Brigitte Lindet, 18 June 2015, 16h,... Marion Decossas, 4 June 2015, 16h, ... Pascale Schellenberger, 21 Mai 2015... F. Leal-Calderon, 7 May 2015, 16h, ... Ibrahim Abdulhalim, 9 April 2015, 1... Manon Carré, 26 March 2015, 14h, ... C. Bure & JM Schmitter, 19 March 20... T. Ogata & H. Ihara, 17 March 2015,... Banafshe Larijani, 12 March 2015, 1...
Événements Nouveau
Patricia DULOR Alain BRISSON Olivier LAMBERT Jochen LANG Pascale SUBRA-PATERNAULT Maria URDACI Marie-Christine DURRIEU Xavier SANTARELLI Gilles GUICHARD Ivan HUC Isabelle BESTEL Juan ELEZGARAY Antoine LOQUET Sophie LECOMTE Reiko ODA Marc BONNEU

Structure et Activité des Macromolécules Biologiques

     

 

Research activities in the group aim at understanding biological processes and their mechanistic aspects based on the 3-dimensional atomic structure of biological macromolecules or assemblies. Use of X-ray crystallography as a major tool coupled to different biochemical and biological techniques is made. Current interests include:

     -    Enzymes and metabolic pathways,
     -    Recognition of protein surfaces by foldamers,
     -    Proteins of therapeutic interest.

       -     Bioprocess Engineering

 

 

Enzymes and Metabolic pathways:

Most of the enzymes that control each step of the flavonoid biosynthetic pathway have been identified from a molecular and biochemical point of view. Nevertheless, little is known about the structural and mechanistic properties of enzymes which catalyze the last steps of the pathway leading to anthocyanins and proanthocyanidins, two major classes of compounds known to contribute to the organoleptic properties of many plant products and to have beneficial effects on human health.

 

Structural investigations at atomic resolution, together with binding-equilibrium and kinetic studies, constitute useful tools to elucidate how enzymes work in the context of molecular pathways in the cell. Current investigations concern enzymes such as dyhydroflavonol 4-reductase (DFR), anthocyanidin and leucoanthocyanidin reductases, anthocyanin synthase and others from Vitis vinefera.

 

    Collaborations:

    -   Pr S. Delrot, ISVV, Villenave d’Ornon (France),
    -   Pr S. Antonczak, Université de Nice Sophia Antipolis (France).

 

 

In a similar way, we contribute to the investigation of secondary metabolite pathways in model aromatic plants (sweet basil, turmeric and ginger). Enzymes under investigation are curcuma synthases, polyketide synthases and double bond reductases involved in the biosynthesis of curcuminoids and gingerols.

 

    Collaboration:

      -  Dr D.R. Gang, Institute of Biological Chemistry, Washington State University (USA).

 

 

Recognition of protein surfaces by foldamers:

 Protein-protein interactions are a central issue in biological processes, and represent relevant therapeutic targets for the treatment of many diseases. The design of antagonistic molecules directed towards the disruption of these interactions requires the specific recognition of relevant protein surfaces. Aromatic oligomers present all the properties (high functionalization, stability and easy predictability of the structure, length flexibility) to reach that point.

In collaboration with Ivan Huc’s group(*) (who gained large expertise in the biosynthesis of quinoline derived oligoamide foldamers), we are particularly interested in validating a novel approach based on combining covalent attachment and structural characterization to decorate a foldamer with proteinogenic side chains, so that it can bind a given protein surface. Key preliminary results have been obtained using human carbonic anhydrase II. This enzyme was selected as a model system because it crystallizes easily, and it binds inhibitors with an affinity in the nanomolar range. Other proteins are currently being targeted.

(*)http://www.iecb.u-bordeaux.fr/teams/HUC/

 

    Collaborations:

     -  Dr I. Huc, CBMN & IECB, Bordeaux, (France).

     -  Dr C. Mackereth, ARNA INSERM U869, Bordeaux (France).

 

 

Proteins of therapeutic interest:

Mapacalcine: a way to new anti-ischemic protectors

Organ dysfunction due to ischemia, such as myocardial infarction, stroke or organ transplantation (ischemia-reperfusion), represents a major cause of treatment failure. A small protein, the mapacalcine, (MW 19 kDa) produced by the marine sponge Cliona vastifica is a specific blocker of calcium influxes particularly resistant to all known calcium channel blockers. Specific receptors for this protein have been detected in various tissues: intestinal smooth muscle, brain, kidney and liver. We demonstrated that the mapacalcine is able to protect hepatocytes and nervous cells against ischemia, thus increasing cell survival after an ischemic shock.

 

The main goals of the project are:

 - i)   to establish the structure – function relationships of mapacalcine to determine the minimum motif required for its activity,

 - ii) to improve the comprehension of the mechanisms triggering cell death after an ischemic shock,

 - iii)   to explore and apply the anti-ischemic properties of mapacalcine to pathologies linked to ischemia and particularly to organ preservation in graft protocols.

 

 

    Collaborations :

       -  Dr C. Heurteaux & M. Borsotto, IPMC, CNRS, UMR 7275, Valbonne (France) : Equipe Développement de stratégies thérapeutiques innovantes pour le traitement de la dépression et de l'AVC,

      -  Pr T. Hauet, IRTOMIT, INSERM U 1082 Poitiers (France): Ischémie Reperfusion en Transplantation d’Organes Mécanismes et Innovations Thérapeutiques.

   GPC3: the end or the means against hepatocellular carcinoma:

Glypican 3 (GPC3) is a heparan-sulfate proteoglycan of which role in cell signalling remains to be unravelled. As a cell surface GPI-anchored glycoprotein and an extracellular co-receptor, it is involved in the control of growth factor/receptor interactions. GPC3 acts upstream of key signalling pathways (Wnt/β-catenin, Hh, BMP and FGF) involved in numerous cell functions.

Intriguingly GPC3 has opposite effects in several cancers. It acts as a tumour gene suppressor in lung and breast cancers, and as an oncogene in hepatocellular carcinoma and hepatoblastoma.

Our studies aim at getting more insights into GPC3 function at the molecular and cellular levels. Our strategy is based on the design and production of stable GPC3 mutants exhibiting well-defined activities on tumour cell growth. Solving the GPC3 3D structure is the starting point to identify small inhibitors by molecular docking. Identification of GPC3 partners allows getting more insights into the signalling pathways involved in tumorigenesis and possibly opens the way to new therapeutic strategies.

 

    Collaborations:

      - Dr C. Grosset, INSERM U1053, Bordeaux (France),

 

    Oxidized HDL-Apolipprotein A1 as a risk predictor of cardiovascular disorders and development of novel diagnostics

 

Hence, early detection of Tyrosine modifications is key in the rapid diagnostics ofcardiovascular disorders. In this project, we will focus on developing methods touniquely identify specific modification of residues in ApoA1 using immunologicalmethods, and test their efficacy on patients.

 

 Collaborations: 

Prof. M.A. Vijayalakshmi & Pr. K. Venkataraman (CBST VIT University (India), Dr. S. Kashikar (GeNext Genomics Private Ltd, India), Dtr.D.Balvay (SPAN Diagnostics S.A.R.L., France). This work is supported by

Biotechnology Industry Research Assistance Council (BIRAC), French Embassy in India, Ministry of Foreign Affairs, Government of France and Indo-French Centre for the Promotion of Advanced Research (CEFIPRA) under
Indo-French Challenge-oriented Call for proposals 2014.

 

 

       Recombinants antibodies and fragments, tools for health: Vectorization for diagnosis and  therapy

Collaboration:

Dr. G. Clofent-Sanchez (CNRS UMR 5536).

 

Bioprocess Engineering

            Bioprocess engineering research for in line production of recombinant therapeutic protein, Integrating upstream and downstream processing in a fully continuous  facility.

This research concerns the development of an inline biomanufacturing system from Culture (CHO) to the purified product (recombinant antibody fragments, recombinant proteins) linking the cell culture continuously to purification by semi-continuous chromatography (SMCC). Upstream part of the continuous production of recombinant proteins will study the mode of animal cell culture with biomass recycling (Impact of cellular recycling system, Impact of oxygen transfer strategy, Impact culture conditions on the final product).

This work is under an industrial Chaire in Bioprocess engineering including several industrial partners as Dr. G.Fleury (SERVIER, France), Mr.Z. Popse (Global Process Concept SARL, France) and Ms A. Lahile (Merck, France).

 

            Development of innovative processes to produce and purify recombinant proteins

Production processes optimization (Batch, Fed-Batch), Development of purification methods and protein - ligand (chromatography) interaction study.

 

 

Chef d'équipe

SANTARELLI Xavier

Xavier SANTARELLI

Professeur

CBMN @ ENSTBB

Ecole Nationale Supérieure de Technologie des Biomolécules (Bordeaux INP ENSTBB)

146 rue Léo Saignat 33000 Bordeaux

Tél : 05 57 57 10 44

Plan d'accès
CBMN Accueil Intro Actualités Séminaires Pubs (WS) Plateformes
Départements Administration Biologie et Biotechnologie Chimie Biomimétique et Thérapeutique Chimie Biophysique
Un problème sur le site? Contactez notre webmaster : webmaster@cbmn.u-bordeaux.fr
Services Direction Directoire Scientifique Administration Communication Hygiène & Sécurité WEB Editorial Committee Animation Scientifique Conseil d'Unité Plateau Technique Offres d'Emploi
EXT INDIA UMT FOLIES UREKA IPEP master Master AC2QMAPS Réseau RMN Aquitain GEM LIA France-Japan
Équipes Patricia DULOR Alain BRISSON Olivier LAMBERT Jochen LANG Pascale SUBRA-PATERNAULT Maria URDACI Marie-Christine DURRIEU Xavier SANTARELLI Gilles GUICHARD Ivan HUC Isabelle BESTEL Juan ELEZGARAY Antoine LOQUET Sophie LECOMTE Reiko ODA Marc BONNEU
informations Mentions légales Plan d'accès Réalisation : Little Big Studio
Dernière mise à jour : 22/03/2017

CNRS Université de Bordeaux Institut Polytechnique de Bordeaux

CBMN Allée de Geoffroy St Hilaire Bât B14
33600 Pessac
Tél. : +33 (0)5 40 00 68 00
Fax : +33 (0)5 40 00 22 00
Mail : contact@cbmn.u-bordeaux.fr